LGLSX
Price
$54.51
Change
+$0.14 (+0.26%)
Updated
Dec 3 closing price
Net Assets
7.83B
RGAHX
Price
$88.38
Change
+$0.53 (+0.60%)
Updated
Dec 3 closing price
Net Assets
338.91B
Interact to see
Advertisement

LGLSX vs RGAHX

Header iconLGLSX vs RGAHX Comparison
Open Charts LGLSX vs RGAHXBanner chart's image
Lord Abbett Growth Leaders R4
Price$54.51
Change+$0.14 (+0.26%)
VolumeN/A
Net Assets7.83B
American Funds Growth Fund of Amer R5E
Price$88.38
Change+$0.53 (+0.60%)
VolumeN/A
Net Assets338.91B
LGLSX vs RGAHX Comparison Chart in %
View a ticker or compare two or three
VS
LGLSX vs. RGAHX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGLSX is a StrongBuy and RGAHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 339B vs. LGLSX (7.83B). RGAHX pays higher dividends than LGLSX: RGAHX (0.44) vs LGLSX (0.00). LGLSX was incepted earlier than RGAHX: LGLSX (10 years) vs RGAHX (10 years). LGLSX (0.90) is less costly to investors than RGAHX (0.44). LGLSX is a more actively managed with annual turnover of: 94.00 vs. RGAHX (25.00). LGLSX has a lower initial minimum investment than RGAHX: LGLSX (0) vs RGAHX (250). LGLSX annual gain was more profitable for investors over the last year : 15.06 vs. RGAHX (7.14). RGAHX return over 5 years is better than : 32.51 vs. LGLSX (27.93).
LGLSXRGAHXLGLSX / RGAHX
Total Expense Ratio0.900.44205%
Annual Report Gross Expense Ratio0.900.44205%
Fund Existence10 years10 years-
Gain YTD16.88519.10488%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets7.83B339B2%
Annual Yield % from dividends0.000.44-
Returns for 1 year15.067.14211%
Returns for 3 years104.2962.15168%
Returns for 5 years27.9332.5186%
Returns for 10 years140.4993.22151%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDIAX56.63N/A
N/A
Janus Henderson Overseas A
RYOAX67.38N/A
N/A
Rydex Biotechnology H
MUOIX34.37N/A
N/A
Morgan Stanley Instl US Core I
GSEPX75.53N/A
N/A
Goldman Sachs US Equity Insights P
FMCMX48.29N/A
N/A
American Funds AMCAP 529-F-3